Passage Bio, Inc.
PASGNASDAQHealthcare● Active
$5.60
+$0.13(+2.38%)
Market Cap$17963736
P/E Ratio—
52W High$20
52W Low$3.935
Passage Bio, Inc. (PASG) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PASG · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.05B) | ($0.06B) | ($0.10B) | ($0.14B) | ($0.19B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.01B | $0.01B | $0.02B | $0.03B |
| Change in Working Capital | $0.00B | $0.00B | $0.01B | ($0.01B) | $0.01B |
| Net Cash from Operations | ($0.03B) | ($0.05B) | ($0.08B) | ($0.12B) | ($0.13B) |
| Investing Activities | |||||
| Capital Expenditure | $0.00B | ($0.00B) | ($0.00B) | ($0.01B) | ($0.03B) |
| Purchases of Investments | $0.00B | ($0.09B) | ($0.13B) | ($0.16B) | ($0.20B) |
| Sales of Investments | $0.04B | $0.14B | $0.19B | $0.19B | $0.18B |
| Net Cash from Investing | $0.04B | $0.05B | $0.07B | $0.03B | ($0.05B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.00B | $0.01B | $0.00B | ($0.00B) | $0.17B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.03B) | ($0.05B) | ($0.08B) | ($0.12B) | ($0.15B) |
| FCF Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Passage Bio, Inc. data
About Passage Bio, Inc. (PASG) Cash Flow Statement
Passage Bio, Inc. generated operating cash flow of ($0.03B) and free cash flow of ($0.03B) for 2025 — a FCF margin of —. Capital expenditure was $0.00B.
Frequently asked questions
PASG · 4 questionsPassage Bio, Inc. generated free cash flow of ($0.03B) for 2025, up 34.3% year-over-year.
PASG free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10